Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Nadkarni

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Medical Hypotheses|August 1, 1991
Antisense RNA therapy for CML--an hypothesisK S Nadkarni, R H Datar, S G Rao
Indian Journal of Cancer|June 1, 1995
Cost effective treatment of osteogenic sarcoma of the extremitiesK S Nadkarni, S R Shinde, A V Bavdekar, et al.
The Journal of the Association of Physicians of India|June 1, 1992
Pneumocystis carinii pneumonia in untreated acute non-lymphoblastic leukaemiaB N Dhabhar, R S Kelkar, K S Nadkarni, et al.
Indian Journal of Experimental Biology|June 1, 1984
Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1S G Rao, K S Nadkarni, K Joshi, et al.
Leukemia & Lymphoma|December 1, 1992
Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's diseaseA B Pathak, S H Advani, R Gopal, et al.
Leukemia Research|March 10, 1999
Sezary cells with hairy projectionsC N Nair, S Shinde, A Kumar, et al.
The Indian Journal of Medical Research|November 1, 1980
Combination chemotherapy for advanced on-Hodgkin's lymphomaP A Shetty, K S Nadkarni, R S Balavat, et al.
Neoplasma|January 1, 1993
Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patientsJ J Nadkarni, K G Jhaver, A K De, et al.
Indian Journal of Cancer|March 1, 1980
Study of dose-related cyclophosphamide toxicity in patients of head & neck cancersS D Gadgil, P A Shetty, A R Mehta, et al.
Journal of Surgical Oncology|January 1, 1989
Aggressive chemotherapy in endodermal sinus tumorN Athanikar, T K Saikia, G Ramkrishnan, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Medical Hypotheses|August 1, 1991
Antisense RNA therapy for CML--an hypothesisK S Nadkarni, R H Datar, S G Rao
Indian Journal of Cancer|June 1, 1995
Cost effective treatment of osteogenic sarcoma of the extremitiesK S Nadkarni, S R Shinde, A V Bavdekar, et al.
The Journal of the Association of Physicians of India|June 1, 1992
Pneumocystis carinii pneumonia in untreated acute non-lymphoblastic leukaemiaB N Dhabhar, R S Kelkar, K S Nadkarni, et al.
Indian Journal of Experimental Biology|June 1, 1984
Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1S G Rao, K S Nadkarni, K Joshi, et al.
Leukemia & Lymphoma|December 1, 1992
Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's diseaseA B Pathak, S H Advani, R Gopal, et al.
Leukemia Research|March 10, 1999
Sezary cells with hairy projectionsC N Nair, S Shinde, A Kumar, et al.
The Indian Journal of Medical Research|November 1, 1980
Combination chemotherapy for advanced on-Hodgkin's lymphomaP A Shetty, K S Nadkarni, R S Balavat, et al.
Neoplasma|January 1, 1993
Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patientsJ J Nadkarni, K G Jhaver, A K De, et al.
Indian Journal of Cancer|March 1, 1980
Study of dose-related cyclophosphamide toxicity in patients of head & neck cancersS D Gadgil, P A Shetty, A R Mehta, et al.
Journal of Surgical Oncology|January 1, 1989
Aggressive chemotherapy in endodermal sinus tumorN Athanikar, T K Saikia, G Ramkrishnan, et al.
Pageof 5